Multiple genetic loci modulate lung adenocarcinoma clinical staging

Clinical Cancer Research

Volumn 17, Issue 8, 2011, Pages 2410-2416

  Frullanti, Elisa ^a   Galvan, Antonella ^a   Falvella, Felicia S ^a   Manenti, Giacomo ^a   Colombo, Francesca ^a   Vannelli, Alberto ^a   Incarbone, Matteo ^c   Alloisio, Marco ^c   Nosotti, Mario ^b   Santambrogio, Luigi ^b   Gonzalez Neira, Anna ^d   Pastorino, Ugo ^a   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMEOBOX; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MESENCHYME HOMEOBOX 2 GENE; OVERALL SURVIVAL; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KAPLAN-MEIER ESTIMATE; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79954622942     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-2394     Document Type: Article

References (20)

1. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in nonsmall cell lung cancer: a decade of progress. Chest 2002;122:1037-57.
2. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-9. (Pubitemid 37328790)
3. Huang YT, Heist RS, Chirieac LR, Lin X, Skaug V, Zienolddiny S, et al. Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol 2009;27:2660-7.
4. Manenti G, Gariboldi M, Fiorino A, Zanesi N, Pierotti MA, Dragani TA. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res 1997;57:4164-6. (Pubitemid 27413415)
5. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, et al. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 2001;61:8866-72. (Pubitemid 34013902)
6. Sham P, Bader JS, Craig I, O'Donovan M, Owen M. DNA pooling: a tool for large-scale association studies. Nat Rev Genet 2002;3:862-71. (Pubitemid 35303518)
7. Norton N, Williams NM, Williams HJ, Spurlock G, Kirov G, Morris DW, et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet 2002;110:471-8. (Pubitemid 36074993)
8. Galvan A, Falvella FS, Frullanti E, Spinola M, Incarbone M, Nosotti M, et al. Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer. Carcinogenesis 2010;31:462-5.
9. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007;81:559-75. (Pubitemid 47330214)
10. Efron B. Bootstrap methods: another look at the jackknife. Ann Statist 1979;7:1-26.
11. Bowden J, Dudbridge F. Unbiased estimation of odds ratios: combining genomewide association scans with replication studies. Genet Epidemiol 2009;33:406-18.
12. Ohshima J, Haruta M, Arai Y, Kasai F, Fujiwara Y, Ariga T, et al. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor. Genes Chromosomes Cancer 2009;48:1037-50.
13. Cortese R, Hartmann O, Berlin K, Eckhardt F. Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer. Int J Biochem Cell Biol 2008;40:1494-508.
14. Ansari KI, Mandal SS. Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J 2010;277:1790-804.
15. Shah N, Sukumar S. The hox genes and their roles in oncogenesis. Nat Rev Cancer 2010;10:361-71.
16. Heuser M, Yap DB, Leung M, de Algara TR, Tafech A, McKinney S, et al. Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation. Blood 2009;113:1432-43.
17. Bundschu K, Walter U, Schuh K. Getting a first clue about SPRED functions. Bioessays 2007;29:897-907. (Pubitemid 47424899)
18. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007;39:1120-6. (Pubitemid 47340658)
19. Del Mare S, Salah Z, Aqeilan RI. WWOX: its genomics, partners, and functions. J Cell Biochem 2009;108:737-45.
20. Cho S, Kim K, Kim YJ, Lee JK, Cho YS, Lee JY, et al. Joint identification of multiple genetic variants via elastic-net variable selection in a genome-wide association analysis. Ann Hum Genet 2010;74:416-28.